> enlarge <

Letter of Excellence

Consultation in business set-up and development

Medical device start-up Medovent benefits from assistance by ASPIRAS Project Consulting in Pharma and Biotech in the areas of business set-up and development. ASPIRAS' CEO Cathrin Pauly has taken on coaching the newly formed company in business matters on behalf of Medovent's investors High-Tech Gründerfonds, FIB Fonds für Innovation und Beschäftigung and the province of Rhineland-Palatinate.

The cooperation with the team of ASPIRAS has proven to be very successfully in negotiations with the investors as well as in the development of an optimal business strategy of Medovent. We look forward to continue to receive expert consultation in the future to further build up the company.



Dr. Thomas Freier
-CEO-